Literature DB >> 17145102

Hospital-acquired infections related to contaminated substances.

R-P Vonberg1, P Gastmeier.   

Abstract

Drug-related outbreaks are frequently reported from various medical departments. A systematic review was performed to describe characteristics of these outbreaks and to determine the most frequent occasions in which contamination of substances for patient care take place. Articles were assessed by a search of the outbreak database, a search of PubMed, and hand search of reference lists from relevant articles. Articles published before 1990 were excluded. Data on affected patients, hospital-acquired infections, substances, pathogens and graded information about the location of the contamination incidence were extracted. A total of 2250 patients in 128 articles were included, mostly from intensive care units or haematological departments. Septicaemia was the most frequent hospital-acquired infection. Most often articles report contamination of blood products and heparin-sodium chloride solutions. The most frequent pathogens were hepatitis A virus, Yersinia enterocolitica, and Serratia spp. for blood products and Burkholderia cepacia and Enterobacter spp. for substances other than blood products. Mortality was highest if red blood cells or total parenteral nutrition formulas were contaminated. In 64 of the outbreaks multi-dose vials had been used against the manufacturers' recommendations. Thus, drug-related outbreaks are likely to occur particularly when basic hygiene measures are disobeyed. A large proportion of drug-related nosocomial infections could have been prevented, for example, by avoiding the use of multi-dose vials.

Entities:  

Mesh:

Year:  2006        PMID: 17145102     DOI: 10.1016/j.jhin.2006.09.018

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  22 in total

Review 1.  Role of phages in the pathogenesis of Burkholderia, or 'Where are the toxin genes in Burkholderia phages?'.

Authors:  Elizabeth J Summer; Jason J Gill; Chris Upton; Carlos F Gonzalez; Ry Young
Journal:  Curr Opin Microbiol       Date:  2007-08-23       Impact factor: 7.934

2.  Targeting the rpoB gene using nested PCR-restriction fragment length polymorphism for identification of nontuberculous mycobacteria in hospital tap water.

Authors:  Ji-Hyun Shin; Hae-Kyung Lee; Eun-Jin Cho; Jae-Yon Yu; Yeon-Ho Kang
Journal:  J Microbiol       Date:  2008-12-24       Impact factor: 3.422

3.  Serratia sp. bacteremia in Canberra, Australia: a population-based study over 10 years.

Authors:  H J Engel; P J Collignon; P T Whiting; K J Kennedy
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-02-05       Impact factor: 3.267

4.  Traceability of biopharmaceuticals in spontaneous reporting systems: a cross-sectional study in the FDA Adverse Event Reporting System (FAERS) and EudraVigilance databases.

Authors:  Niels S Vermeer; Sabine M J M Straus; Aukje K Mantel-Teeuwisse; Francois Domergue; Toine C G Egberts; Hubert G M Leufkens; Marie L De Bruin
Journal:  Drug Saf       Date:  2013-08       Impact factor: 5.606

5.  Safety profile of biological medicines as compared with non-biologicals: an analysis of the italian spontaneous reporting system database.

Authors:  Paola M Cutroneo; Valentina Isgrò; Alessandra Russo; Valentina Ientile; Laura Sottosanti; Giuseppe Pimpinella; Anita Conforti; Ugo Moretti; Achille P Caputi; Gianluca Trifirò
Journal:  Drug Saf       Date:  2014-11       Impact factor: 5.606

6.  Whole Genome Sequence Analysis of Burkholderia contaminans FFH2055 Strain Reveals the Presence of Putative β-Lactamases.

Authors:  José J Degrossi; Cindy Merino; Adela M Isasmendi; Lorena M Ibarra; Chelsea Collins; Nicolás E Bo; Mariana Papalia; Jennifer S Fernandez; Claudia M Hernandez; Krisztina M Papp-Wallace; Robert A Bonomo; Miryam S Vazquez; Pablo Power; María S Ramirez
Journal:  Curr Microbiol       Date:  2019-02-19       Impact factor: 2.188

7.  Outbreak of adverse reactions associated with contaminated heparin.

Authors:  David B Blossom; Alexander J Kallen; Priti R Patel; Alexis Elward; Luke Robinson; Ganpan Gao; Robert Langer; Kiran M Perkins; Jennifer L Jaeger; Katie M Kurkjian; Marilyn Jones; Sarah F Schillie; Nadine Shehab; Daniel Ketterer; Ganesh Venkataraman; Takashi Kei Kishimoto; Zachary Shriver; Ann W McMahon; K Frank Austen; Steven Kozlowski; Arjun Srinivasan; George Turabelidze; Carolyn V Gould; Matthew J Arduino; Ram Sasisekharan
Journal:  N Engl J Med       Date:  2008-12-03       Impact factor: 91.245

8.  Population-based laboratory surveillance for Serratia species isolates in a large Canadian health region.

Authors:  K B Laupland; M D Parkins; D B Gregson; D L Church; T Ross; J D D Pitout
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-10-25       Impact factor: 3.267

Review 9.  A systematic review and meta-analysis of microbial contamination of parenteral medication prepared in a clinical versus pharmacy environment.

Authors:  Karin H M Larmené-Beld; Henderik W Frijlink; Katja Taxis
Journal:  Eur J Clin Pharmacol       Date:  2019-01-25       Impact factor: 2.953

10.  Serratamolide is a hemolytic factor produced by Serratia marcescens.

Authors:  Robert M Q Shanks; Nicholas A Stella; Roni M Lahr; Shaoru Wang; Tara I Veverka; Regis P Kowalski; Xinyu Liu
Journal:  PLoS One       Date:  2012-05-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.